Skip to main content

About Us

Pharming is a global biopharmaceutical company dedicated to transforming the lives of patients with rare, debilitating, and life-threatening diseases.

Pharming is commercializing and developing an innovative portfolio of protein replacement therapies and precision medicines, including small molecules, biologics, and gene therapies that are in early to late-stage development.

Our Strengths

Our key strengths include the following:

  • Sales growth of our commercialized asset.

  • Proven rare-disease commercialization capabilities.

  • Internal pipeline of product candidates.

  • Transgenic Production Platform Technology.

  • Data exclusivity, know-how and intellectual property.

Our Strategy

Our goal is to be a leading biopharmaceutical company focused on offering treatment options for patients with unmet medical needs, focused on rare diseases.

Our three-pillar strategy for achieving our goal is:

  • Continuing to grow sales of our commercialized asset through further country launches.

  • Expanding indications for rhC1INH and clinical development and commercialization of new recombinant human proteins using our platform technology.

  • In-licensing or acquiring drug candidates that are in the late-stages of clinical development and that can potentially leverage our commercial infrastructure.

Cookies: This website uses cookies Check the cookies page for more information Accept Decline